UK markets closed

Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.81-0.30 (-4.22%)
At close: 04:00PM EDT
6.91 +0.10 (+1.47%)
After hours: 06:02PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
79,926
143,235
47,699
74,854
-
Other short-term investments
183,514
139,879
118,283
0
-
Total cash
263,440
283,114
165,982
74,854
-
Other current assets
3,992
2,071
948
1,160
-
Total current assets
267,432
285,185
166,930
90,869
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,638
3,206
2,231
1,864
-
Accumulated depreciation
-1,609
-1,402
-1,185
-689
-
Net property, plant and equipment
1,029
1,804
1,046
1,175
-
Other long-term assets
56
37
94
246
-
Total non-current assets
1,085
1,841
1,140
1,421
-
Total assets
268,517
287,026
168,070
92,290
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
12,880
-
Accounts payable
2,515
1,645
2,126
935
-
Accrued liabilities
2,865
2,134
1,933
6,516
-
Deferred revenues
-
-
0
836
0
Other current liabilities
278
185
358
162
-
Total current liabilities
11,944
8,468
6,820
22,821
-
Non-current liabilities
Deferred tax liabilities
-
-
-
-
345
Total non-current liabilities
1,206
1,615
947
877
-
Total liabilities
13,150
10,083
7,767
23,698
-
Stockholders' equity
Common stock
6
5
3
186,033
-
Retained earnings
-332,628
-242,418
-182,073
-131,915
-
Accumulated other comprehensive income
-19
-822
-338
-124
-
Total stockholders' equity
255,367
276,943
160,303
68,592
-
Total liabilities and stockholders' equity
268,517
287,026
168,070
92,290
-